Drug treatment for psychotic depression [1]

British Journal of Psychiatry

Volumn 189, Issue OCT., 2006, Pages 383-

  Vattakatuchery, J J ^a  

^a Hergest Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL TRIAL; CONFIDENCE INTERVAL; DEPRESSIVE PSYCHOSIS; DRUG DOSE REGIMEN; DRUG EFFICACY; HUMAN; LETTER; META ANALYSIS; MONOTHERAPY; RISK FACTOR; SYSTEMATIC REVIEW;

AFFECTIVE DISORDERS, PSYCHOTIC; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 33750204430     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.189.4.383     Document Type: Letter

References (3)

1. Bruijn, J. A., Moleman, P., Mulder, P. G., et al (1996) A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients. Psychopharmacology, 127, 231-237.
2. van den Broek, W. W., Birkenhäger, T. K., Mulder, P. G., et al (2004) A double-blind randomized study comparing imipramine with fluvoxamine in depressed in-patients. Psychopharmacology, 175, 481-486.
3. Wijkstra, J., Lijmer, J., Balk, F. J., et al (2006) Pharmacological treatment for unipolar psychotic depression: systematic review and meta-analysis. British Journal of Psychiatry, 188, 410-415.